137 related articles for article (PubMed ID: 28535649)
1. [Cancer-associated-fibroblasts regulate the chemoresistance of lung cancer cell line A549 via SDF-1 secretion].
Zou F; Zhang ZH; Zhang YT; Zhao JQ; Zhang XL; Wen CL; Song XY; Zhou WM
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):339-343. PubMed ID: 28535649
[No Abstract] [Full Text] [Related]
2. mir-1-mediated paracrine effect of cancer-associated fibroblasts on lung cancer cell proliferation and chemoresistance.
Li J; Guan J; Long X; Wang Y; Xiang X
Oncol Rep; 2016 Jun; 35(6):3523-31. PubMed ID: 27035564
[TBL] [Abstract][Full Text] [Related]
3. Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway.
Xia R; Xu G; Huang Y; Sheng X; Xu X; Lu H
Life Sci; 2018 May; 201():111-120. PubMed ID: 29604270
[TBL] [Abstract][Full Text] [Related]
4. Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells.
Lei X; Huang Z; Zhong M; Zhu B; Tang S; Liao D
Acta Biochim Biophys Sin (Shanghai); 2007 May; 39(5):344-50. PubMed ID: 17492131
[TBL] [Abstract][Full Text] [Related]
5. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.
Tang CH; Tan TW; Fu WM; Yang RS
Carcinogenesis; 2008 Jan; 29(1):35-43. PubMed ID: 17916907
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells.
Wang L; Li X; Ren Y; Geng H; Zhang Q; Cao L; Meng Z; Wu X; Xu M; Xu K
Cancer Sci; 2019 May; 110(5):1609-1620. PubMed ID: 30868675
[TBL] [Abstract][Full Text] [Related]
7. Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells.
Huang YC; Hsiao YC; Chen YJ; Wei YY; Lai TH; Tang CH
Biochem Pharmacol; 2007 Dec; 74(12):1702-12. PubMed ID: 17904532
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblast-derived SDF-1 induces epithelial-mesenchymal transition of lung adenocarcinoma via CXCR4/β-catenin/PPARδ signalling.
Wang Y; Lan W; Xu M; Song J; Mao J; Li C; Du X; Jiang Y; Li E; Zhang R; Wang Q
Cell Death Dis; 2021 Feb; 12(2):214. PubMed ID: 33637678
[TBL] [Abstract][Full Text] [Related]
9. Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform.
Ying L; Zhu Z; Xu Z; He T; Li E; Guo Z; Liu F; Jiang C; Wang Q
PLoS One; 2015; 10(6):e0129593. PubMed ID: 26115510
[TBL] [Abstract][Full Text] [Related]
10. [Multi-channel promotion of lung cancer progress by bone marrow derived mesenchymal stem cells in tumor microenvironment].
Luo D; Hu SY; Liu GX
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):85-91. PubMed ID: 29502366
[No Abstract] [Full Text] [Related]
11. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
Hartmann TN; Burger JA; Glodek A; Fujii N; Burger M
Oncogene; 2005 Jun; 24(27):4462-71. PubMed ID: 15806155
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
13. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells.
Kijowski J; Baj-Krzyworzeka M; Majka M; Reca R; Marquez LA; Christofidou-Solomidou M; Janowska-Wieczorek A; Ratajczak MZ
Stem Cells; 2001; 19(5):453-66. PubMed ID: 11553854
[TBL] [Abstract][Full Text] [Related]
14. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
[TBL] [Abstract][Full Text] [Related]
17. Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway.
Zhang Q; Yang J; Bai J; Ren J
Cancer Sci; 2018 Apr; 109(4):944-955. PubMed ID: 29383798
[TBL] [Abstract][Full Text] [Related]
18. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
20. Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation.
Wald O; Izhar U; Amir G; Kirshberg S; Shlomai Z; Zamir G; Peled A; Shapira OM
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1503-12. PubMed ID: 21463876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
